Adage Capital Partners Gp, L.L.C. Roivant Sciences Ltd. Transaction History

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,082,383 shares of ROIV stock, worth $24.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,082,383

Previous 3,819,983 45.49%

Holding current value

$24.1 Million

Previous $38.5 Million 39.11%

% of portfolio

0.04%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$9.08 - $11.62 $15.8 Million - $20.2 Million	-1,737,600 Reduced 45.49%	2,082,383 $23.5 Million
Q1 2025 May 15, 2025	SELL	$10.09 - $12.08 $19.2 Million - $23 Million	-1,900,000 Reduced 33.22%	3,819,983 $38.5 Million
Q4 2024 Feb 14, 2025	SELL	$11.16 - $12.71 $387,832 - $441,697	-34,752 Reduced 0.6%	5,719,983 $67.7 Million
Q3 2024 Nov 14, 2024	BUY	$10.17 - $12.5 $18.5 Million - $22.7 Million	1,819,983 Added 46.25%	5,754,735 $66.4 Million
Q1 2024 May 15, 2024	SELL	$9.87 - $11.8 $13.2 Million - $15.8 Million	-1,340,248 Reduced 25.41%	3,934,752 $41.5 Million
Q4 2023 Feb 14, 2024	SELL	$8.38 - $11.58 $7.75 Million - $10.7 Million	-925,000 Reduced 14.92%	5,275,000 $59.2 Million
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $47.7 Million - $64.5 Million	-4,890,300 Reduced 44.1%	6,200,000 $72.4 Million
Q2 2023 Aug 14, 2023	SELL	$7.09 - $10.08 $26.9 Million - $38.2 Million	-3,790,625 Reduced 25.47%	11,090,300 $112 Million
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $40.7 Million - $58.7 Million	5,882,486 Added 65.37%	14,880,925 $110 Million
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $17.8 Million - $42.3 Million	5,298,439 Added 143.2%	8,998,439 $71.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $1.38 Million - $13.1 Million	2,700,000 Added 270.0%	3,700,000 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $2.81 Million - $4.84 Million	1,000,000 New	1,000,000 $4.07 Million

Others Institutions Holding ROIV

# of Institutions

361

Shares Held

456M

Call Options Held

8.34M

Put Options Held

720K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.15B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Roivant Sciences Ltd. Transaction History